PURPOSES: @entity2318 ( @entity2318 ) is a rare and severe complication after cesarean section. The incidence of @entity2318 has been increased significantly in recent years. In this retrospective case study of 131 @entity2318 @entity1 , the therapeutic effects and prognosis were compared between the two treatment groups: uterine artery embolization and systemic @entity1499 injection conservative therapy. In addition, the necessary of subsequent dilation and curettage as a further treatment was also evaluated. METHODS: The 131 @entity2318 @entity1 were assigned into two groups receiving uterine artery embolization (UAE) or @entity6822 conservative therapy. Based on @entity1 ' myometrial thickness and reducing degree of b-hCG level, each of the two treatment group was further divided into two subgroups according to whether the @entity1 received subsequent dilation and curettage as further treatment. The therapeutic effect of two treatment groups was compared. RESULTS: The results indicated that both UAE and @entity6822 conservative treatment achieved the expected therapeutic effect, and the recovery time in dilation and curettage subgroup was significantly shorter than that of the non-curettage subgroup. One hundred and thirty @entity1 resumed normal menstrual cycles within 3-10  months after the treatment. CONCLUSIONS: The individualized therapeutic regimen is an important factor to achieve the desired therapeutic effect based on the specific indications. Dilation and curettage could shorten the recovery time significantly.

Therapeutic effects of uterine artery embolisation (UAE) and XXXX ( @entity6822 ) conservative therapy used in treatment of cesarean scar pregnancy.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity2318 :: ('MESH:D002921', 'Disease') :: ['Cesarean scar pregnancy', 'CSP'] @entity1499 :: ('MESH:D008727', 'Chemical') :: ['methotrexate'] @entity6822 :: ('D008727', 'Chemical') :: ['MTX']
@entity1499 :: (MESH:D008727,Chemical) :: ['methotrexate']
